Navigation Links


IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation

Animal Data Shows Prolonged Survival AND Increased PlateletConcentrations SCOTTSDALE, Ariz., March 08, 2007 /PRNewswire-FirstCall/ --ImmuneRegen BioSciences, a wholly-owned subsidiary of IRBioSciences Holdings, Inc. announced today that ongoing analysis ofdata acquired from previously performed animal efficacy studies hasrevealed evidence that ImmuneRegen's developmental stage product,Radi...

Data From Adherex's European Phase Ib/II Trial of ADH-1 to be Presented at International Symposium on Targeted Anticancer Therapies

RESEARCH TRIANGLE PARK, N.C., Mar 8, 2007 (CCNMatthews via COMTEXNews Network) -- Adherex Technologies Inc. (TSX:AHX)(AMEX:ADH), abiopharmaceutical company with a broad portfolio of oncologyproducts under development, today announced that Dr. AntonellaPerotti, MD, Istituto Nazionale dei Tumori Milano, SENDOFoundation, an investigator in Adherex's European Phase Ib/II studyof single-agent AD...

Arpida adds novel antibiotic AR-2474 to its preclinical pipeline

In vitro microbiology and proof of concept in topical models ofinfection REINACH / BASEL, Switzerland, 8 March 2007 - Arpida Ltd.(SWX: ARPN) today announced positive results of in vitromicrobiological studies with AR-2474 against a large panel ofclinical isolates, including those resistant to various currenttherapies. In addition, topical applications of AR-2474 were foundto be highly ef...

Antisoma plc (UK) - Second lung cancer trial adds to positive data on AS1404

LONDON and FLORENCE, Italy - 8 March 2007 - Cancer drugdeveloper Antisoma plc (LSE: ASM, US OTC: ATSMY) today announcespositive initial findings from its second, confirmatory phase IItrial of AS1404 in non-small cell lung cancer. This 30-patient trial tested an 1800 mg/m2 dose of AS1404 incombination with carboplatin and paclitaxel chemotherapy.Investigators reported a response rate of 50...

Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder

National Autism Association calls 2006 Pediatrics study fatallyflawed CHICAGO, March 07, 2007 /PRNewswire-USNewswire/ -- New findingspresented yesterday at a National Autism Association meetingbolster claims that vaccines may play a role in the development ofautism spectrum disorders. David Ayoub, MD presented datasuggesting a correlation between mercury- containing vaccines andrates of pe...

Why Is Polio Spreading in Pakistan?

LEWISVILLE, Texas, March 8, 2007--The World Health Organizationhas released new figures that show that polio cases are rising inPakistan. So is this another instance where, as leftist groups constantlyclaim, the pharmaceutical industry is denying important vaccines topoor populations? Um, apparently not. According to London’s Guardiannewspaper, “parents of 24,000 children i...

Scottish Scientists Test ‘Secret Weapon’ Against Tumours

LONDON, March 8, 2007--Cancer Research UK scientists in Glasgowhave devised a new method of attacking cancer cells. They reportthe findings in the Journal of Clinical Investigation* today(Thursday). A team of scientists from the Beatson Institute for CancerResearch gave mice a chemical that caused cancer cells to commitsuicide, significantly slowing the growth of the tumours they werecar...

Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success

Huge clinical development program of first-in-class CB1antagonist rimonabant to show benefits beyond weight reduction andavoid image as life-style drug BARCELONA, Spain | March 08, 2007 | The Business Intelligencefirm La Merie S.L. reported today that Sanofi-Aventis’first-in-class CB1 antagonist Acomplia (rimonabant) has at leastfive competitors in clinical stages up to phase III an...

Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 8, 2007 - Magen BioSciences,Inc., a specialty dermatology company, today announced thepublication of a paper in the March 9, 2007 issue of the journalCell by its co-founder and board member, David E. Fisher, M.D.,Ph.D., that identifies two new functions for an important protein,p53, in the pigmentation of skin. Fisher's study shows that inaddition to i...

Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University

SAN DIEGO--(BUSINESS WIRE)--Mar 8, 2007 - Vaxiion Therapeutics,Inc. today announced that its researchers, in collaboration withSan Diego State University, have discovered a 'minicell' vaccinedelivery system that has potential to protect against severaldisease-causing infections. These findings were published in an advance online edition ofthe journal, Vaccine, and the paper was published to...
[previous] [next]
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of ... collection of specialty vendors and unique items from across the nation, this holiday-themed event ... wellness services offered by the VNA. The boutique will be open Saturday, November ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: